Preclinical evaluation of protein synthesis inhibitor omacetaxine in pediatric brainstem gliomasYongjuan Chen(UNSW Sydney), David S. Ziegler(Children's Cancer Institute Australia)Neuro-Oncology AdvancesJanuary 1, 202410.1093/noajnl/vdae029Cited by 2SaveCiteExport RISWatch citationsRelated PapersDual targeting of mitochondrial function and mTOR pathway as a therapeutic strategy for diffuse intrinsic pontine glioma|Oncotarget|2018|88